GCTS(GCTS)
GCTS
Q4 2026 EPS Estimate
$-0.16
Nov 11, 2026 · Reports after close
Revenue Estimate
$1M
Analyst Sentiment
Wall St. Consensus
Buy2 analysts·Low coverage
75
Score
2 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$3.00
+60.9%
Consensus
$3.00
+60.9%
Bull
$3.00
+60.9%
12-Month Target Range2 analysts
$3.00$3.00$3.00
Current $1.86Consensus
Current Price
$1.86
Upside to Consensus
$1.14
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+563.14%
EPS—
FY2028
Rev-4.11%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $10M | $63M | $61M |
| Low | $6M | $32M | $38M |
| High | $13M | $95M | $83M |
| EBITDA Avg | $-8M | $-56M | $-54M |
| Low | $-11M | $-84M | $-74M |
| High | $-6M | $-28M | $-34M |
| EBIT Avg | $-9M | $-60M | $-57M |
| Low | $-12M | $-90M | $-79M |
| High | $-6M | $-30M | $-36M |
| Net Income Avg | $-28M | $-5M | $-28M |
| Low | $-34M | $-31M | $-42M |
| High | $-25M | $-4M | $-14M |
| EPS Avg | $-0.56 | $-0.34 | $-0.53 |
| Low | $-0.65 | $-0.59 | $-0.79 |
| High | $-0.47 | $-0.08 | $-0.27 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1M | $5M | $6M | $7M | $8M | $10M | $13M | $14M |
| Low | $1M | $2M | $3M | $4M | $5M | $6M | $8M | $8M |
| High | $1M | $9M | $8M | $10M | $12M | $15M | $17M | $19M |
| EBITDA Avg | $-1M | $-5M | $-5M | $-6M | $-7M | $-9M | $-11M | $-12M |
| Low | $-1M | $-8M | $-7M | $-9M | $-10M | $-13M | $-15M | $-17M |
| High | $-1M | $-2M | $-3M | $-4M | $-5M | $-6M | $-7M | $-7M |
| EBIT Avg | $-1M | $-5M | $-5M | $-7M | $-8M | $-10M | $-12M | $-13M |
| Low | $-1M | $-8M | $-7M | $-9M | $-11M | $-14M | $-17M | $-18M |
| High | $-1M | $-2M | $-3M | $-4M | $-5M | $-6M | $-7M | $-8M |
| Net Income Avg | $-12M | $-10M | $-14M | $-13M | $-12M | $-12M | $-12M | $-12M |
| Low | $-16M | $-13M | $-21M | $-20M | $-19M | $-19M | $-18M | $-18M |
| High | $-7M | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M |
| EPS Avg | $-0.14 | $-0.13 | $-0.17 | $-0.16 | $-0.15 | $-0.15 | $-0.14 | $-0.14 |
| Low | $-0.20 | $-0.16 | $-0.26 | $-0.24 | $-0.23 | $-0.23 | $-0.21 | $-0.21 |
| High | $-0.09 | $-0.09 | $-0.08 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |